Our Commitment to Improving Population Health in Heart Disease
After decades of decline, the number of Americans dying from cardiovascular disease has been rising steadily in recent years. Cardiovascular disease, sometimes referred to as heart disease, is a group of conditions that involve the heart and blood vessels. Common complications include heart attack, stroke and death.
Lives claimed by cardiovascular disease in the United States: 1920 - 20171
Source: National Heart, Lung, and Blood Institute tabulation using National Vital Statistics System
Reducing cardiovascular disease impact is an urgent national need2-4
NEARLY HALF of all US adults have some type of cardiovascular disease.
1 IN EVERY 4 deaths is related to cardiovascular disease each year in the United States.
Certain communities, for instance, Black Americans are 30% MORE LIKELY to die of cardiovascular disease than others.
Source: American Heart Association, 2019
Source: Centers for Disease Control and Prevention, 2020
Source: Graham, 2015
To address these alarming trends, new and transformative approaches are needed to proactively predict, prevent and better treat heart disease. At Novartis, we are collaborating on innovative population health approaches that go beyond medicines to reduce heart disease and its impact—equitably and at scale.
Our vision is to contribute to meaningful, enduring change for generations to come and be a trusted partner in the communities we serve. We believe that by combining knowledge and resources, we can reduce the burden of heart disease and address healthcare disparities for underserved populations and ensure that all patients – regardless of ethnicity, socioeconomic status, gender or geography – receive the care they need.
Learn more about how we are collaborating to reimagine and improve cardiovascular patient care, by exploring, introducing and championing innovative population health solutions: